{
    "clinical_study": {
        "@rank": "119608", 
        "arm_group": [
            {
                "arm_group_label": "Arm A", 
                "arm_group_type": "Active Comparator", 
                "description": "Neoadjuvant Chemoradiotherapy + Chemotherapy + Surgery"
            }, 
            {
                "arm_group_label": "Arm B", 
                "arm_group_type": "Active Comparator", 
                "description": "Neoadjuvant Chemotherapy + Surgery"
            }
        ], 
        "brief_summary": {
            "textblock": "RATIONALE: Drugs used in chemotherapy, such as docetaxel and cisplatin, use different ways\n      to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses\n      high-energy x-rays to damage tumor cells. Giving chemotherapy with radiation therapy before\n      surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be\n      removed. It is not yet known if chemotherapy plus radiation therapy is more effective than\n      chemotherapy alone before surgery in treating non-small cell lung cancer.\n\n      PURPOSE: This randomized phase III trial is studying docetaxel and cisplatin with or without\n      radiation therapy to see how well they work when given before surgery in treating patients\n      with stage IIIA non-small cell lung cancer that has spread to lymph nodes in the chest."
        }, 
        "brief_title": "Preoperative Chemoradiotherapy vs. Chemotherapy Alone in NSCLC Patients", 
        "completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Lung Cancer", 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma, Non-Small-Cell Lung", 
                "Lung Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "The main objective of this trial is to compare feasibility and efficacy of sequential\n      neoadjuvant chemoradiotherapy with 44 Gy concomitant boost to neoadjuvant chemotherapy\n      alone.\n\n      Secondary objectives are to assess the value of PET in predicting pathological response and\n      eventfree survival in stage IIIA NSCLC, and a health economic analysis of the two regimens.\n      Further to compare the amount of serum DNA in patients with stage IIIA, pN2 NSCLC before\n      chemotherapy, before surgery and at the second follow-up visit (i.e. four months after\n      surgery or treatment failure for patients who can not be operated) in patients randomized\n      into the trial SAKK 16/00 and to correlate the DNA variation with tumor response, remission\n      duration and overall survival.\n\n      OUTLINE: This is a prospective randomized phase III trial. Patients are stratified according\n      to mediastinal bulk (5 cm or more vs less than 5 cm), weight loss in the past 6 months (5%\n      or more vs less than 5%), and participating center. Patients are randomized to 1 of 2\n      treatment arms."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "DISEASE CHARACTERISTICS:\n\n          -  Histologically or cytologically confirmed non-small cell lung cancer\n\n               -  Squamous, adenosquamous, large cell, or poorly differentiated\n\n          -  Stage IIIA (T1-3, N2, M0)\n\n               -  N2 disease confirmed by 1 of the following:\n\n                    -  Mediastinoscopy\n\n                    -  Bronchoscopy with fine-needle aspiration or esophagoscopy\n\n                         -  All N3 lymph nodes must be negative by positron-emission tomography\n                            (PET) AND CT scan (< 1 cm in the largest diameter)\n\n                    -  PET scan\n\n                         -  Both the primary tumor and at least 1 N2 lymph node must be positive\n                            in PET scan\n\n                         -  At least 1 of the PET scan positive N2 lymph nodes is positive in the\n                            CT scan (> 1 cm in the largest diameter)\n\n                         -  All N3 lymph nodes negative in PET scan\n\n        PATIENT CHARACTERISTICS:\n\n        Age:\n\n          -  18 to 75\n\n        Performance status:\n\n          -  WHO 0-1\n\n        Life expectancy:\n\n          -  Not specified\n\n        Hematopoietic:\n\n          -  WBC at least 4,000/mm^3\n\n          -  Platelet count at least 100,000/mm^3\n\n        Hepatic:\n\n          -  Bilirubin normal\n\n          -  AST/ALT no greater than 1.5 times upper limit of normal (ULN)\n\n          -  Alkaline phosphatase no greater than 2.5 times ULN\n\n        Renal:\n\n          -  Creatinine clearance greater than 60 mL/min\n\n        Cardiovascular:\n\n          -  Cardiac function normal\n\n          -  No unstable cardiac disease requiring treatment\n\n          -  No congestive heart failure\n\n          -  No angina pectoris even if medically controlled\n\n          -  No significant arrhythmia\n\n          -  No myocardial infarction in the past 3 months\n\n        Pulmonary:\n\n          -  Lung function appropriate\n\n        Neurologic:\n\n          -  No history of significant neurologic or psychiatric disorders\n\n          -  No psychotic disorders\n\n          -  No dementia\n\n          -  No seizures\n\n        Other:\n\n          -  No other prior or concurrent malignancies except nonmelanoma skin cancer, adequately\n             treated carcinoma in situ of the cervix, or any other neoplastic disease with a\n             disease-free interval \u2265 5 years\n\n          -  No active uncontrolled infection\n\n          -  No uncontrolled diabetes mellitus\n\n          -  No gastric ulcers\n\n          -  No pre-existing peripheral neuropathy greater than grade 1\n\n          -  No contraindications to corticosteroids\n\n          -  No other serious underlying medical condition that would preclude study participation\n\n          -  No socioeconomic or geographic condition that would preclude study participation\n\n          -  Not pregnant or nursing\n\n          -  Fertile patients must use effective contraception\n\n        PRIOR CONCURRENT THERAPY:\n\n        Biologic therapy:\n\n          -  Not specified\n\n        Chemotherapy:\n\n          -  No prior cytostatic chemotherapy\n\n        Endocrine therapy:\n\n          -  No concurrent prednisone except for treatment of acute hypersensitivity reactions or\n             chronic low-dose treatment initiated more than 6 months prior to study entry (i.e.,\n             no greater than 20 mg methylprednisolone or equivalent)\n\n        Radiotherapy:\n\n          -  No prior radiotherapy to chest\n\n        Surgery:\n\n          -  Not specified\n\n        Other:\n\n          -  At least 30 days since participation in another clinical study\n\n          -  No other concurrent experimental drugs"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "232", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 14, 2002", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00030771", 
            "org_study_id": "SAKK 16/00", 
            "secondary_id": [
                "SWS-SAKK-16/00", 
                "EU-20138"
            ]
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Arm A", 
                    "Arm B"
                ], 
                "description": "Docetaxel (Taxotere\u00ae) 85 mg/m2 1 hour iv infusion d1 Cisplatin 100 mg/m2 1 hour iv infusion d1 Schedule: 3 cycles repeated every 21 days", 
                "intervention_name": "Chemotherapy", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Arm A", 
                "description": "Radiotherapy (3 weeks after last chemotherapy administration) 44 Gy in 22 fractions concomitant boost technique in 3 weeks", 
                "intervention_name": "Radiotherapy", 
                "intervention_type": "Radiation"
            }, 
            {
                "arm_group_label": [
                    "Arm A", 
                    "Arm B"
                ], 
                "description": "3-4 weeks after termination of radiotherapy", 
                "intervention_name": "Surgery", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "squamous cell lung cancer", 
            "large cell lung cancer", 
            "stage IIIA non-small cell lung cancer", 
            "adenosquamous cell lung cancer"
        ], 
        "lastchanged_date": "December 12, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Loewenstein", 
                        "country": "Germany", 
                        "zip": "74245"
                    }, 
                    "name": "Klinik Loewenstein gGmbH"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mannheim", 
                        "country": "Germany", 
                        "zip": "D-68135"
                    }, 
                    "name": "Klinikum der Stadt Mannheim"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sremska Kamenica", 
                        "country": "Serbia", 
                        "zip": "21204"
                    }, 
                    "name": "Institut za plucne bolesti"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sremska Kamenica", 
                        "country": "Serbia", 
                        "zip": "21204"
                    }, 
                    "name": "Institute of Oncology"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Aarau", 
                        "country": "Switzerland", 
                        "zip": "CH-5001"
                    }, 
                    "name": "Kantonsspital Aarau"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Baden", 
                        "country": "Switzerland", 
                        "zip": "CH-5404"
                    }, 
                    "name": "Kantonsspital Baden"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Baden", 
                        "country": "Switzerland", 
                        "zip": "CH-5404"
                    }, 
                    "name": "Kantonsspital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Basel", 
                        "country": "Switzerland", 
                        "zip": "CH-4016"
                    }, 
                    "name": "Saint Claraspital AG"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Basel", 
                        "country": "Switzerland", 
                        "zip": "CH-4031"
                    }, 
                    "name": "Universitaetsspital-Basel"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bellinzona", 
                        "country": "Switzerland", 
                        "zip": "6500"
                    }, 
                    "name": "Istituto Oncologico della Svizzera Italiana - Ospedale Regionale Bellinzona e Valli"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bern", 
                        "country": "Switzerland", 
                        "zip": "CH-3010"
                    }, 
                    "name": "Inselspital Bern"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bruderholz", 
                        "country": "Switzerland", 
                        "zip": "CH-4101"
                    }, 
                    "name": "Kantonsspital Bruderholz"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chur", 
                        "country": "Switzerland", 
                        "zip": "CH-7000"
                    }, 
                    "name": "Kantonsspital Graubuenden"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Freiburg", 
                        "country": "Switzerland", 
                        "zip": "1708"
                    }, 
                    "name": "Kantonsspital Freiburg"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Geneva", 
                        "country": "Switzerland", 
                        "zip": "CH-1211"
                    }, 
                    "name": "Hopital Cantonal Universitaire de Geneve"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lausanne", 
                        "country": "Switzerland", 
                        "zip": "1011"
                    }, 
                    "name": "Centre Pluridisciplinaire d' Oncologie"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Liestal", 
                        "country": "Switzerland", 
                        "zip": "CH-4410"
                    }, 
                    "name": "Kantonsspital Liestal"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Olten", 
                        "country": "Switzerland", 
                        "zip": "CH-4600"
                    }, 
                    "name": "Kantonsspital Olten"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rheinfelden", 
                        "country": "Switzerland", 
                        "zip": "4310"
                    }, 
                    "name": "FMH Onkologie/Haematologie"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Gallen", 
                        "country": "Switzerland", 
                        "zip": "CH-9007"
                    }, 
                    "name": "Kantonsspital - St. Gallen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Thun", 
                        "country": "Switzerland", 
                        "zip": "3600"
                    }, 
                    "name": "Regionalspital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Winterthur", 
                        "country": "Switzerland", 
                        "zip": "CH-8400"
                    }, 
                    "name": "Kantonsspital Winterthur"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Zurich", 
                        "country": "Switzerland", 
                        "zip": "CH-8063"
                    }, 
                    "name": "City Hospital Triemli"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Zurich", 
                        "country": "Switzerland", 
                        "zip": "CH-8091"
                    }, 
                    "name": "UniversitaetsSpital Zuerich"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Zurich", 
                        "country": "Switzerland", 
                        "zip": "8038"
                    }, 
                    "name": "Onkozentrum"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "Germany", 
                "Serbia", 
                "Switzerland"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "Preoperative Chemoradiotherapy vs. Chemotherapy Alone in Non-small Cell Lung Cancer (NSCLC) Patients With Mediastinal Lymph Node Metastases (Stage IIIA, N2): A Randomized Prospective Phase III Trial", 
        "overall_official": [
            {
                "affiliation": "Kantonsspital Winterthur KSW", 
                "last_name": "Miklos Pless, MD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Centre Hospitalier Universitaire Vaudois", 
                "last_name": "Hans-Beat Ris, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Universitaetsspital-Basel", 
                "last_name": "Diana Naehrig, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Centre Hospitalier Universitaire Vaudoise", 
                "last_name": "Roger Stupp, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Switzerland: Swissmedic / Swiss Federal Health Office", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "October 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Event-free survival", 
            "safety_issue": "No", 
            "time_frame": "1 month after surgery"
        }, 
        "reference": {
            "PMID": "19086609", 
            "citation": "Tieu BH, Sanborn RE, Thomas CR Jr. Neoadjuvant therapy for resectable non-small cell lung cancer with mediastinal lymph node involvement. Thorac Surg Clin. 2008 Nov;18(4):403-15. Review."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00030771"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Postoperative mortality assessed", 
                "safety_issue": "No", 
                "time_frame": "1 month after surgery"
            }, 
            {
                "measure": "Toxicity", 
                "safety_issue": "Yes", 
                "time_frame": "During treatment"
            }, 
            {
                "measure": "Complete resection rate after surgery", 
                "safety_issue": "No", 
                "time_frame": "1 month after surgery"
            }, 
            {
                "measure": "Objective response rate measured after completion of  chemoradiotherapy", 
                "safety_issue": "No", 
                "time_frame": "43 days"
            }, 
            {
                "measure": "Operability", 
                "safety_issue": "No", 
                "time_frame": "1 month after chemo"
            }, 
            {
                "measure": "Overall survival", 
                "safety_issue": "Yes", 
                "time_frame": "Follow-up until death of patient"
            }, 
            {
                "measure": "Failure pattern", 
                "safety_issue": "No", 
                "time_frame": "Follow-up until death"
            }
        ], 
        "source": "Swiss Group for Clinical Cancer Research", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Swiss Group for Clinical Cancer Research", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2001", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }, 
    "geocoordinates": {
        "Centre Pluridisciplinaire d' Oncologie": "46.52 6.634", 
        "City Hospital Triemli": "47.369 8.539", 
        "FMH Onkologie/Haematologie": "47.552 7.793", 
        "Hopital Cantonal Universitaire de Geneve": "46.198 6.142", 
        "Inselspital Bern": "46.948 7.445", 
        "Institut za plucne bolesti": "45.222 19.844", 
        "Institute of Oncology": "45.222 19.844", 
        "Istituto Oncologico della Svizzera Italiana - Ospedale Regionale Bellinzona e Valli": "46.198 9.027", 
        "Kantonsspital": "47.474 8.306", 
        "Kantonsspital - St. Gallen": "47.424 9.371", 
        "Kantonsspital Aarau": "47.391 8.046", 
        "Kantonsspital Baden": "47.474 8.306", 
        "Kantonsspital Bruderholz": "47.528 7.581", 
        "Kantonsspital Freiburg": "46.802 7.146", 
        "Kantonsspital Graubuenden": "46.857 9.527", 
        "Kantonsspital Liestal": "47.482 7.74", 
        "Kantonsspital Olten": "47.35 7.92", 
        "Kantonsspital Winterthur": "47.5 8.738", 
        "Klinik Loewenstein gGmbH": "49.114 9.365", 
        "Klinikum der Stadt Mannheim": "49.461 8.49", 
        "Onkozentrum": "47.369 8.539", 
        "Regionalspital": "46.748 7.626", 
        "Saint Claraspital AG": "47.557 7.593", 
        "UniversitaetsSpital Zuerich": "47.369 8.539", 
        "Universitaetsspital-Basel": "47.557 7.593"
    }
}